Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates

PLoS Pathogens(2021)10.1371/journal.ppat.1009736Source: DataRank Database

Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0.691. It has been cited 28 times, with 15 citing works in its 1-hop citation network.

N/A

0.691DataRank · unranked

Scored on demand from live citation data

Open Access28 citations · 15 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (22 grants)Impact (FWCI 3.29)OA: goldTopics (93)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 73%Citation Network 27%

Base Score Contribution

0.505

From this paper's citation signal

Citation Network Contribution

0.186

From 11 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 15 citers.

A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
Nature Medicine2021166 citations92 referencesContributes 0.056
Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism
Biochemical Pharmacology202411 citations56 referencesContributes 0.044
Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein
PLoS Pathogens202312 citations100 referencesContributes 0.026
A SMART method for isolating monoclonal antibodies from individual rhesus macaque memory B cells
Journal of Immunological Methods20232 citations50 referencesContributes 0.022
A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence
PLoS Pathogens20226 citations107 referencesContributes 0.018

Authors (19)

Marlies M. van Haaren ORCID,Hui Li ORCID,Laura E. McCoy ORCID,Colin Havenar‐Daughton ORCID,Christopher A. Cottrell ORCID

Live enrichment

PubMed:34432859 PMC:PMC8423243 OpenAlex:https://openalex.org/W3194793001

HIV Vaccine Research and Design (HIVRAD) program

Grant: P01 Al110657

NIH CHAVI-ID

Grant: UM1 AI100663

CHAVD

Grant: UM1 AI44462

NIH R01

Grant: AI13082

Bill and Melinda Gates Foundation CAVD

Grant: OPP1115782, OPP1132237, OPP1084519, OPP119635, INV-002022

European Union’s Horizon 2020 research and innovation program

Grant: 681137

European AIDS Vaccine Initiative 2020

amfAR Mathilde Krim Fellowship

Grant: 109514-61-RKVA

NIAID NIH HHS

Grant: R01 AI131331

NIAID NIH HHS

Grant: R61 AI161818

NIAID NIH HHS

Grant: UM1 AI144462

NIAID NIH HHS

Grant: R01 AI165080

NIAID NIH HHS

Grant: P01 AI110657

NIAID NIH HHS

Grant: P01 AI131251

NIAID NIH HHS

Grant: R01 AI160607

NIAID NIH HHS

Grant: R01 AI036082

NIAID NIH HHS

Grant: F31 AI131873

National Institutes of Health

Grant: 2P01AI110657-06

Cleaved, stabilized HIV-1 Env trimers for structural and vaccine studies

National Institutes of Health

Grant: 3UM1AI100663-04S1

Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery

the International AIDS Vaccine Initiative Neutralizing Antibody Center

2017 AMC Fellowship

2017 AMC Ph.D. Scholarship

Dutch Research Council (NWO)

FWCI

3.29

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009736&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009736&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1009736

journalhttps://doi.org/10.1371/journal.ppat.1009736

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34432859

Fields of Study

HIV Research and Treatmentinterferon and immune responsesHerpesvirus Infections and Treatments0301 basic medicine03 medical and health sciences0303 health sciencesAIDS VaccinesAnimalsAntibodies, MonoclonalAntibodies, NeutralizingAntibody FormationAntigens, ViralEpitopesHIV AntibodiesHIV InfectionsHIV-1HumansImmunizationInfantKenyaPrimatesProtein MultimerizationSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusVaccinationenv Gene Products, Human Immunodeficiency Virus

MeSH Terms

AnimalsAntibodies, MonoclonalAntibody FormationEpitopesAntigens, ViralHumansImmunizationInfantKenyaPrimatesVaccinationSimian Immunodeficiency VirusHIV AntibodiesHIV-1HIV InfectionsSimian Acquired Immunodeficiency SyndromeAIDS Vaccinesenv Gene Products, Human Immunodeficiency VirusProtein MultimerizationAntibodies, NeutralizingSimian immunodeficiency virus

Keywords

VirologyAntibodyEpitopeImmunologyImmunizationMonoclonal antibodyAIDS VaccinesImmunogenBiologyHIV vaccineNeutralizing antibodyAntigenImmune systemVaccine trialPrimatesQH301-705.5Simian Acquired Immunodeficiency SyndromeHIV InfectionsHIV AntibodiesIMMUNOGENICITYMicrobiologyEpitopesELICITATIONAnimalsHumansBiology (General)Antigens, ViralScience & TechnologyPOTENTVaccinationenv Gene Products, Human Immunodeficiency VirusAntibodies, MonoclonalInfantRC581-607Antibodies, NeutralizingKenyaCELLSAntibody FormationHIV-1ParasitologySimian Immunodeficiency VirusImmunologic diseases. AllergyProtein MultimerizationLife Sciences & BiomedicineBROADLY NEUTRALIZING ANTIBODIESResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being